<VariationArchive VariationID="840283" VariationName="NM_000108.5(DLD):c.1416_1422del (p.Tyr473fs)" VariationType="Deletion" Accession="VCV000840283" Version="11" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-17" DateCreated="2020-04-15" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="832784" VariationID="840283">
      <GeneList>
        <Gene Symbol="DLD" FullName="dihydrolipoamide dehydrogenase" GeneID="1738" HGNC_ID="HGNC:2898" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q31.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="107891107" stop="107921198" display_start="107891107" display_stop="107921198" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="107531585" stop="107561642" display_start="107531585" display_stop="107561642" Strand="+" />
          </Location>
          <OMIM>238331</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000108.5(DLD):c.1416_1422del (p.Tyr473fs)</Name>
      <CanonicalSPDI>NC_000007.14:107919046:TGGAATATGGA:TGGA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q31.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="107919047" stop="107919053" display_start="107919047" display_stop="107919053" variantLength="7" positionVCF="107919046" referenceAlleleVCF="TTGGAATA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="107559492" stop="107559498" display_start="107559492" display_stop="107559498" variantLength="7" positionVCF="107559491" referenceAlleleVCF="TTGGAATA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Y473fs</ProteinChange>
      <ProteinChange>Y425fs</ProteinChange>
      <ProteinChange>Y374fs</ProteinChange>
      <ProteinChange>Y450fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.107559496_107559502del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.107559496_107559502del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.107919051_107919057del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.107919051_107919057del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008045.1" sequenceAccession="NG_008045" sequenceVersion="1" change="g.32911_32917del">
            <Expression>NG_008045.1:g.32911_32917del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000108.5" sequenceAccession="NM_000108" sequenceVersion="5" change="c.1416_1422del" MANESelect="true">
            <Expression>NM_000108.5:c.1416_1422del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000099.2" sequenceAccession="NP_000099" sequenceVersion="2" change="p.Tyr473fs">
            <Expression>NP_000099.2:p.Tyr473fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289750.1" sequenceAccession="NM_001289750" sequenceVersion="1" change="c.1119_1125del">
            <Expression>NM_001289750.1:c.1119_1125del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276679.1" sequenceAccession="NP_001276679" sequenceVersion="1" change="p.Tyr374fs">
            <Expression>NP_001276679.1:p.Tyr374fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289751.1" sequenceAccession="NM_001289751" sequenceVersion="1" change="c.1347_1353del">
            <Expression>NM_001289751.1:c.1347_1353del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276680.1" sequenceAccession="NP_001276680" sequenceVersion="1" change="p.Tyr450fs">
            <Expression>NP_001276680.1:p.Tyr450fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289752.1" sequenceAccession="NM_001289752" sequenceVersion="1" change="c.1272_1278del">
            <Expression>NM_001289752.1:c.1272_1278del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276681.1" sequenceAccession="NP_001276681" sequenceVersion="1" change="p.Tyr425fs">
            <Expression>NP_001276681.1:p.Tyr425fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1214130226" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000108.5(DLD):c.1416_1422del (p.Tyr473fs) AND Pyruvate dehydrogenase E3 deficiency" Accession="RCV001042237" Version="11">
        <ClassifiedConditionList TraitSetID="3242">
          <ClassifiedCondition DB="MedGen" ID="C5574660">Pyruvate dehydrogenase E3 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-02-07" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-07" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-04-15" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21930696</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27544700</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27896107</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8968745</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-11">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2023-12-29">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-05-29">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-03-22">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="3242" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9028" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lipoamide dehydrogenase deficiency, lactic acidosis due to</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lipoamide dehydrogenase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="238331.0010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dihydrolipoamide Dehydrogenase (E3) Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Maple syrup urine disease, type 3</ElementValue>
                <XRef ID="Maple+syrup+urine+disease+type+1B/4456" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MAPLE SYRUP URINE DISEASE, TYPE III</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DLD DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">E3 DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dihydrolipoamide Dehydrogenase E3 Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pyruvate dehydrogenase E3 deficiency</ElementValue>
                <XRef ID="MONDO:0009529" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DLDD</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MSUD3</ElementValue>
                <XRef Type="MIM" ID="246900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3263" />
                <XRef ID="3263" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypes of dihydrolipoamide dehydrogenase (DLD) deficiency are an overlapping continuum that ranges from early-onset neurologic manifestations to adult-onset liver involvement and, rarely, a myopathic presentation. Early-onset DLD deficiency typically manifests in infancy as hypotonia with lactic acidosis. Affected infants frequently do not survive their initial metabolic decompensation, or die within the first few years of life during a recurrent metabolic decompensation. Children who live beyond the first two to three years frequently exhibit growth deficiencies and residual neurologic deficits (intellectual disability, spasticity, ataxia, and seizures). In contrast, isolated liver involvement can present as early as the neonatal period and as late as the third decade. Evidence of liver injury/failure is preceded by nausea and emesis and frequently associated with encephalopathy and/or coagulopathy. Acute metabolic episodes are frequently associated with lactate elevations, hyperammonemia, and hepatomegaly. With resolution of the acute episodes affected individuals frequently return to baseline with no residual neurologic deficit or intellectual disability. Liver failure can result in death, even in those with late-onset disease. Individuals with the myopathic presentation may experience muscle cramps, weakness, and an elevated creatine kinase.</Attribute>
                <XRef ID="NBK220444" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25032271</ID>
                <ID Source="BookShelf">NBK220444</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="2394" DB="Orphanet" />
              <XRef ID="765" DB="Orphanet" />
              <XRef ID="C5574660" DB="MedGen" />
              <XRef ID="MONDO:0009529" DB="MONDO" />
              <XRef Type="MIM" ID="246900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2371149" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4871423|MedGen:CN043137" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001205910" DateUpdated="2024-02-14" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27896107</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8968745</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21930696</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27544700</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr473Hisfs*6) in the DLD gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 37 amino acid(s) of the DLD protein. This premature translational stop signal has been observed in individual(s) with dihydrolipoamide dehydrogenase deficiency (PMID: 27896107). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the DLD protein in which other variant(s) (p.Arg495Gly) have been determined to be pathogenic (PMID: 8968745, 21930696, 27544700). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 840283).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DLD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.107559492_107559498del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN043137" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7842186" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000108.5:c.1416_1422del|OMIM:246900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004193955" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000108.5:c.1416_1422del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="246900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2371149" TraitType="Disease" MappingType="XRef" MappingValue="CN043137" MappingRef="MedGen">
        <MedGen CUI="C5574660" Name="Pyruvate dehydrogenase E3 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7842186" TraitType="Disease" MappingType="XRef" MappingValue="246900" MappingRef="OMIM">
        <MedGen CUI="C5574660" Name="Pyruvate dehydrogenase E3 deficiency" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001524433</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

